Researchers from Lund University in Sweden have developed a blood test with the potential to provide information leading to the diagnosis of Alzheimer’s.

A wide-ranging global study has shown the test’s ability to discriminate between persons with and without Alzheimer’s disease by measuring the tau proteins found in the brain.

Whereas currently diagnosis often takes place post-mortem, this blood test could provide a relatively reliable indicator of Alzheimer’s in living people.

It is hoped the test may be able to detect the disease as early as 20 years before the onset of cognitive impairment in persons at known genetic risk.

The broader implications of the blood test are wide, potentially unlocking enhanced diagnosis, care and even prevention.

Read more about the global study at: https://www.sciencedaily.com/releases/2020/07/200729114404.htm.

Sign up to our newsletter to receive the latest industry news, research papers and information about FloMedical.

Scroll to Top